ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9533
0.06%
Brent Oil
83.585
0.05%
Bitcoin
57,930.79
-0.53%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Maravai LifeSciences Holdings Inc (MRVI)

  7. Maravai LifeSciences Holdings Inc (MRVI) Noticias

MRVI Maravai LifeSciences Holdings Inc

8.42
0.22 (2.68%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Maravai LifeSciences Holdings Inc MRVI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.22 2.68% 8.42 18:48:32
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.23 8.13 8.74 8.42 8.20
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:49BWTriLink BioTechnologies® et Lonza signent un contrat de..
30/4/202406:31BWTriLink BioTechnologies® and Lonza Enter into Non-exclusive..
18/4/202414:12BWTriLink BioTechnologies® annonce un nouveau site à San Diego..
18/4/202414:09BWTriLink BioTechnologies® kündigt neue Anlage in San Diego..
18/4/202406:36BWTriLink BioTechnologies® Announces New San Diego Facility..
10/4/202415:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
12/3/202415:15GLOBEMaravai LifeSciences Announces March 2024 Investor..
29/2/202416:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:08EDGAR2Form 8-K - Current report
22/2/202415:05GLOBEMaravai LifeSciences Reports Fourth Quarter and Full Year..
21/2/202407:00BWTriLink BioTechnologies® Solidifies IP Position with Awarded..
20/2/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202407:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
08/2/202415:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202407:00GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
18/1/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
16/11/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202307:15GLOBEMaravai LifeSciences Announces November 2023 Investor..
08/11/202316:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:11EDGAR2Form 8-K - Current report
07/11/202315:05GLOBEMaravai LifeSciences Reports Third Quarter 2023 Financial..
02/11/202305:47BWTriLink BioTechnologies® Expands Capabilities with Launch of..
17/10/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202307:15GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
29/9/202307:15GLOBEMaravai LifeSciences Hosts 2023 Investor R&D Day
19/9/202308:31GLOBEMaravai LifeSciences Chief Innovation Officer Kate Broderick..
05/9/202315:15GLOBEMaravai LifeSciences to Host 2023 Investor R&D Day
23/8/202307:15GLOBECygnus Technologies Receives 2023 R&D 100 Award for MockV®..
22/8/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:15GLOBEMaravai LifeSciences Announces August 2023 Investor..
08/8/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202315:19EDGAR2Form 8-K - Current report
07/8/202315:05GLOBEMaravai LifeSciences Reports Second Quarter 2023 Financial..
27/7/202315:11EDGAR2Form 8-K - Current report
27/7/202315:05GLOBEMaravai LifeSciences Announces Completion of Planned CEO..
24/7/202315:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
20/7/202315:08EDGAR2Form 8-K - Current report
20/7/202315:05GLOBEMaravai LifeSciences Announces Appointment of New Director..
19/7/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202307:00GLOBECongressman Scott Peters Tours Maravai’s RNA manufacturing..
24/5/202315:58BWトライリンク・バイオテクノロジーズ®が製造能力拡張を発表、mRNA製造施設が完成間近

Su Consulta Reciente

NASDAQ
MRVI
Maravai LifeSciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados